E37: Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively Worth $10B+

Errik Anderson sits down with David Weisburd to discuss Pro-noia, the potential of the biotech industry, and the 82VS Seed Fund investment approach. They discuss practicing Pro-noia, the value of building a portfolio of relationships, and the idea of a forever company. (0:00) Introduction to Errik Anderson and his concept of Pro Noya (10:22)The potential scale of platform building in the biotech industry (20:22)Leading with work and following with capital - the approach at 82VS Seed Fund (28:13)Practicing Pro Noya: Cultivating optimism and generosity (33:35)Building a portfolio of relationships and the compounding value (40:01)Errik Anderson on involving his family in his work (46:00)Errik Anderson's management style: micro-managing or detailed involvement? (54:09)Errik Anderson explains the concept of a forever company (57:00)Collaborating with big pharmaceutical companies like Pfizer (1:00:56)Launch of the Tenex Capital Podcast newsletter powered by Carrie Alabs